Who owns Pharmacyclics?

Key details on Pharmacyclics (Ticker: PCYC)

Who owns Pharmacyclics?

Is PCYC a good stock to own? Find out who bought Pharmacyclics, who sold Pharmacyclics (PCYC) stock, and who holds a large position in Pharmacyclics.

Fund Name Number of Shares Share Valuation As Of
T. Rowe Price Associates 9.60M $2.46B March 31, 2015
Baker Bros. Advisors 9.04M $2.31B March 31, 2015
Ameriprise Financial 4.97M $607.49M Dec. 31, 2014
Vanguard 3.92M $1.00B March 31, 2015
Barclays 2.70M $74.92M March 31, 2012
PRIMECAP Management Company 2.28M $584.60M March 31, 2015
Pentwater Capital Management 2.23M $571.54M March 31, 2015
OrbiMed Advisors 2.18M $32.29M Dec. 31, 2011
FMR 2.00M $235.40M Sept. 30, 2014
Capital World Investors^ 1.98M $242.62M Dec. 31, 2014
SUSQUEHANNA INTERNATIONAL 1.71M $201.11M Sept. 30, 2014
Visium Asset Management 1.68M $91.47M June 30, 2012
BlackRock Institutional Trust Company, N.A. 1.55M $395.87M March 31, 2015
BlackRock Fund Advisors 1.49M $381.46M March 31, 2015
FRED ALGER MANAGEMENT 1.46M $146.80M March 31, 2014
Columbus Circle Investors 1.36M $144.08M Dec. 31, 2013
GOLDMAN SACHS 1.34M $134.27M March 31, 2014
STATE STREET CORPORATION 1.15M $293.96M March 31, 2015
QVT Financial 1.12M $16.58M Dec. 31, 2011
Janus Capital Management 974991 $249.43M March 31, 2015

Who sold Pharmacyclics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Franklin Resources Sept. 30, 2011 1.23M $14.60M
BVF Sept. 30, 2011 1.16M $13.70M
Balyasny Asset Management March 31, 2011 1.75M $10.28M
Sectoral Asset Management March 31, 2011 1.02M $5.98M
Perceptive Advisors Dec. 31, 2010 2.81M $17.07M